Colutellin A, an immunosuppressive peptide from Colletotrichum dematium

References

1. Andoh T. F., Burdmann E. A., Fransechini N., Houghton D. C., Bennett W. M. 1996; Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 50:1110–1117
   [Google Scholar]
2. Barnett H. L., Hunter B. 1999 Illustrated Genera of Imperfect Fungi, 4th edn. St Paul, MN: APS Press;
3. Castillo U., Myers S., Browne L., Strobel G., Hess W. M., Hanks J., Reay D. 2005; Scanning electron microscopy of some endophytic streptomycetes in snakevine – Kennedia nigricans. Scanning 27:305–311
   [Google Scholar]
4. Castillo U. F., Strobel G. A., Mullenberg K., Condron M. M., Teplow D., Folgiano V., Gallo M., Ferracane R., Mannina L. other authors 2006; Munumbicins E-4 and E-5: novel broad spectrum antibiotics from Streptomyces NRRL 3052. FEMS Microbiol Lett 255:296–300
   [Google Scholar]
5. Castillo U. F., Browne L., Strobel G. A., Hess W. M., Ezra S., Pacheco G., Ezra D. 2007; Biologically active endophytic streptomycetes from Nothofagus spp. and other plants in Patagonia. Microb Ecol 53:12–19
   [Google Scholar]
6. Clark L. B., Appleby M. W., Brukow M. E., Wilkinson J. E., Ziegler S. F., Ramsdell F. 1999; Cellular and molecular characterization of the scurfy mouse mutant. J Immunol 162:2546–2554
   [Google Scholar]
7. Daoud D., Scheld H. H., Speckmann E. J., Gorji A. 2007; Rapamycin: brain excitability studied in vitro. Epilepsia 48:834–836
   [Google Scholar]
8. Dreyfuss M. M., Chapela I. H. 1994; Potential of fungi in the discovery of novel, low molecular-weight pharmaceuticals. Biotechnology 26:49–80
   [Google Scholar]
9. Ezra D., Hess W. M., Strobel G. A. 2004; Unique wild type endophytic isolates of Muscodor albus, a volatile antibiotic producing fungus. Microbiology 150:4023–4031
   [Google Scholar]
10. Froud T., Baidal D. A., Ponte G., Ferreira J. V., Ricordi C., Alejandro R. 2006; Resolution of neurotoxicity and beta-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF. Cell Transplant 15:613–620
    [Google Scholar]
11. Harel A., Bercovich S., Yarden O. 2006; Calcineurin is required for sclerotial development and pathogenicity of Sclerotinia sclerotiorum in an oxalic acid-independent manner. Mol Plant Microbe Interact 19:682–693
    [Google Scholar]
12. Jegorov A., Matha V., Sedmera P., Havlicek V., Stuchlik J., Seidel P., Simek P. 1995; Cyclosporins from Tolypocladium terricola. Phytochemistry 38:403–407
    [Google Scholar]
13. Lawen A., Traber R., Reuille R., Ponelle M. 1994; In vitro biosynthesis of ring-extended cyclosporins. Biochem J 300:395–399
    [Google Scholar]
14. Lu G., Cannon P., Reid A., Simmons C. 2004; Diversity and molecular relationships of endophytic Colletotrichum isolates from the Iwokrama Forest Reserve, Guyana. Mycol Res 108:53–63
    [Google Scholar]
15. Mann J. 2001; Natural products as immunosuppressive agents. Nat Prod Rep 18:417–430
    [Google Scholar]
16. Rehacek Z. 1995; The cyclosporins. Folia Microbiol (Praha 40:68–88
    [Google Scholar]
17. Rodríguez M. A., Cabrera G., Godeas A. 2006; Cyclosporine A from a nonpathogenic Fusarium oxysporum suppressing Sclerotinia sclerotiorum. J Appl Microbiol 100:575–586
    [Google Scholar]
18. Ruegger A., Kuhn M., Lichti H., Loosli H.-R., Huguenin R., Quiquerez C., Wartburg A. V. 1976; Cyclosporin A, ein immunosuppressive wirksamer Peptidmetabolite aus Trichoderma polysporum (Link ex Pers.) Rifai. Helv Chim Acta 59:1075–1092
    [Google Scholar]
19. Sakamoto K., Tsujii E., Miyauchi M., Nakanishi T., Yamashita M., Shigematsu N., Tada T., Izumi S., Okuhara M. 1993; FR901459, a novel immunosuppressant isolated from Stachybotrys chartarum. No. 19392. Taxonomy of the producing organism, fermentation, isolation, physico-chemical properties and biological activities. J Antibiot (Tokyo) 46:1788–1798
    [Google Scholar]
20. Silverstein R. M., Bassler G. C., Morrill T. C. 1991 Spectrometric Identification of Organic Compounds New York: Wiley;
21. Steinbach W. J., Reedy J. L., Cramer R. A. Jr, Perfect J. R., Heitman J. 2007; Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 5:418–430
    [Google Scholar]
22. Strobel G. A., Daisy B. 2003; Bioprospecting for microbial endophytes and their natural products. Microbiol Mol Biol Rev 67:491–502
    [Google Scholar]
23. Strobel G., Daisy B., Castillo U., Harper J. 2004; Natural products from endophytic microorganisms. J Nat Prod 67:257–268
    [Google Scholar]
24. Sutton B. C. 1980 The Coelomycetes Kew, UK: CMI;
25. Tanabe K. 2003; Calcineurin inhibitors in renal transplantation: what is the best option?. Drugs 63:1535–1548
    [Google Scholar]
26. Traber R., Dreyfuss M. M. 1996; Occurrence of cyclosporins and cyclosporin-like peptides in fungi. J Ind Microbiol Biotechnol 17:397–401
    [Google Scholar]
27. Umland S. P., Shak H., Jahway J., Shortfall J., Razae S., Garlisi C. G., Falcone A., Kung T. T., Stelts D. other authors 1999; Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production and murine pulmonary inflammation. Am J Respir Cell Mol Biol 20:481–492
    [Google Scholar]